Abstract
Many clinically important or mechanistically interesting inhibitors react with enzymes by a branched pathway in which inactivation of the enzyme and formation of product are competing reactions. The steady-state kinetics for this pathway [Waley (1980) Biochem. J. 185, 771-773] gave equations for progress curves that were cumbersome. A convenient linear plot is now described. The time (t1/2) for 50% inactivation of the enzyme (this is also the time for 50% formation of product), or for 50% loss of substrate, is measured in a series of experiments in which the concentration of inhibitor, [I]0, is varied; in these experiments the ratio of the concentration of enzyme to the concentration of inhibitor is kept fixed. Then a plot of [I]0 X t1/2 against [I]0 is linear, and the kinetic parameters can be found from the slope and intercept. Furthermore, simplifications of the equations for progress curves are described that are valid when the concentration of inhibitors is high, or is low, or when the extent of reaction is low. The use of simulated data has shown that the recommended methods are not unduly sensitive to experimental error.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Frère J. M., Dormans C., Lenzini V. M., Duyckaerts C. Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J. 1982 Dec 1;207(3):429–436. doi: 10.1042/bj2070429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knight G. C., Waley S. G. Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide. Biochem J. 1985 Jan 15;225(2):435–439. doi: 10.1042/bj2250435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee H. J., Wilson I. B. Enzymic parameters: measurement of V and Km. Biochim Biophys Acta. 1971 Sep 22;242(3):519–522. doi: 10.1016/0005-2744(71)90144-6. [DOI] [PubMed] [Google Scholar]
- Ortiz de Montellano P. R., Mico B. A. Destruction of cytochrome P-450 by allylisopropylacetamide is a suicidal process. Arch Biochem Biophys. 1981 Jan;206(1):43–50. doi: 10.1016/0003-9861(81)90063-1. [DOI] [PubMed] [Google Scholar]
- Selwyn M. J. A simple test for inactivation of an enzyme during assay. Biochim Biophys Acta. 1965 Jul 29;105(1):193–195. doi: 10.1016/s0926-6593(65)80190-4. [DOI] [PubMed] [Google Scholar]
- Tatsunami S., Yago N., Hosoe M. Kinetics of suicide substrates. Steady-state treatments and computer-aided exact solutions. Biochim Biophys Acta. 1981 Dec 15;662(2):226–235. doi: 10.1016/0005-2744(81)90034-6. [DOI] [PubMed] [Google Scholar]
- Tipton K. F., Fowler C. J., McCrodden J. M., Strolin Benedetti M. The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions. Biochem J. 1983 Jan 1;209(1):235–242. doi: 10.1042/bj2090235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waley S. G. Kinetics of suicide substrates. Biochem J. 1980 Mar 1;185(3):771–773. doi: 10.1042/bj1850771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walsh C. T. Suicide substrates, mechanism-based enzyme inactivators: recent developments. Annu Rev Biochem. 1984;53:493–535. doi: 10.1146/annurev.bi.53.070184.002425. [DOI] [PubMed] [Google Scholar]
- Wharton C. W., Szawelski R. J. Half-time analysis of the integrated Michaelis equation. Simulation and use of the half-time plot and its direct linear variant in the analysis of some alpha-chymotrypsin, papain- and fumarase-catalysed reactions. Biochem J. 1982 May 1;203(2):351–360. doi: 10.1042/bj2030351. [DOI] [PMC free article] [PubMed] [Google Scholar]
